Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.9B | 10.8B | 9.8B | 9.1B |
| Cost of revenue | 6.0B | 6.8B | 6.2B | 5.6B |
| Gross profit | 3.9B | 4.0B | 3.6B | 3.5B |
| Operating expense | ||||
| Research & development | 359M | 385M | 331M | 300M |
| Selling general and admin | 1.6B | 1.1B | 2.0B | 1.6B |
| Other operating expenses | — | — | — | — |
| Operating income | 2.0B | 2.6B | 1.2B | 1.6B |
| Non operating interest income | ||||
| Income | 173M | 197M | 187M | 200M |
| Expense | 210M | 224M | 251M | 248M |
| Other income expense | 279M | -287M | 717M | -134M |
| Pretax income | 2.2B | 2.3B | 1.9B | 1.4B |
| Tax provision | 283M | 395M | 198M | 125M |
| Net income | 2.0B | 1.9B | 1.8B | 1.3B |
| Basic EPS | 9.3 | 8.8 | 8.6 | 5.8 |
| Diluted EPS | 9.2 | 8.8 | 8.5 | 5.8 |
| Basic average shares | 214M | 215.8M | 218.6M | 217.8M |
| Diluted average shares | 215.6M | 217.0M | 219.6M | 220M |
| EBITDA | 2.8B | 3.5B | 2.1B | 2.4B |
| Net income from continuing op. | 2.0B | 1.9B | 1.7B | 1.3B |
| Minority interests | 5M | 7M | 10M | -2M |
| Preferred stock dividends | — | — | — | — |